Related Experiment Video

Updated: Aug 24, 2026

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

Drug-induced hyperthermia in Huntington's disease

D Gaasbeek1, P Naarding, T Stor

  • 1Nursing Home Heemhof, Apeldoorn, The Netherlands.

Journal of Neurology
|April 15, 2004
PubMed

Insights

Huntington's disease patients are at increased risk for developing severe drug-induced hyperthermia, including neuroleptic malignant syndrome (NMS) and serotonin syndrome. Advanced disease and other factors may contribute to these life-threatening events.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Huntington's disease (HD) is a progressive neurodegenerative disorder.
  • Neuroleptic Malignant Syndrome (NMS) and Serotonin Syndrome are severe adverse drug reactions.

Observation:

  • Four advanced-stage Huntington's disease patients developed drug-induced hyperthermia (NMS or Serotonin Syndrome) within a year.
  • Contributing factors may include advanced neurological disease, severe illness, summer season, infections, dehydration, and pre-existing extra-pyramidal signs.

Findings:

  • Huntington's disease patients may have an increased susceptibility to NMS and Serotonin Syndrome.
  • Pre-existing extra-pyramidal signs in HD can mask early symptoms of NMS/Serotonin Syndrome.

Implications:

  • Awareness of these risks is crucial for clinicians managing Huntington's disease patients.
  • Preventive measures and careful medication management are essential to avoid potentially fatal hyperthermic reactions.

More Related Videos

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

Protocol for Long Duration Whole Body Hyperthermia in Mice08:10

Protocol for Long Duration Whole Body Hyperthermia in Mice

Published on: August 25, 2012

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...